Group 1 - Weigao Group (01066.HK) announced a share buyback on February 5, 2026, spending HKD 544,000 to repurchase 102,000 shares at a price range of HKD 5.23 to HKD 5.36 per share [1] - BlackRock increased its stake in Weigao Group by acquiring 5,591,600 shares [1]

Group 1 - The company, Weigao Group (01066), announced a share buyback on February 5, 2026, for a total expenditure of HKD 544,000 [1] - The buyback involves repurchasing 102,000 shares [1]

FF305 第 1 頁 共 6 頁 v 1.3.0 FF305 確認 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 山東威高集團醫用高分子製品股份有限公司 呈交日期： 2026年2月5日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01066 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | 事件 | | 已發行股份（ ...

格隆汇2月4日丨根据联交所最新权益披露资料显示，2026年1月29日，威高股份(01066.HK)获BlackRock, Inc.在场内以每股均价5.2566港元增持559.16万股， 涉资约2939.28万港元。 | 表格序號 | 大股東/董事/最高行政人員名 作出披露的 買入 / 賣出或涉及的 每股的平均價 | | | | 持有權益的股份數目 佔已發行的 有關事件的日期 相 | | | --- | --- | --- | --- | --- | --- | --- | | | 股份數目 | 原因 | | | (請參閱上述*註 | 有投票權股 (日 / 月 / 年) 材 | | | | | | | | 份百分比 | | CS20260203E00524 | BlackRock, Inc. | 1001(L) | 5.591.600(L | HKD 5.2566 | 230.410.501(L) | 5.09(L)29/01/2026 | 增持后，BlackRock, Inc.最新持股数目为230,410,501股，持股比例由4.97%上升至5.09%。 | 股份代號: | | --- | | 上市法國名稱: ...

威高股份(01066)发布公告，于2026年2月4日该公司斥资51.94万港元回购10万股，回购价格为每股5.18- 5.20港元。 ...

智通财经APP讯，威高股份(01066)发布公告，于2026年2月4日该公司斥资51.94万港元回购10万股，回 购价格为每股5.18-5.20港元。 ...

格隆汇2月4日丨威高股份(01066.HK)发布公告，2026年2月4日耗资51.94万港元回购10万股，回购价格 每股5.18-5.2港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 山東威高集團醫用高分子製品股份有限公司 呈交日期： 2026年2月4日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01066 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | ...

Group 1: Domestic News - The 2026 Central Document was released, focusing on agricultural modernization and rural revitalization, emphasizing the need for reforms in rural collective property rights and controlling new village-level debts [2] - The document encourages the use of special bonds and long-term treasury bonds to support major projects in agriculture and rural areas, enhancing the effectiveness of financial support for agriculture [2] Group 2: Monetary Policy - The central bank announced an increase in the amount of 3-month reverse repos, conducting an operation of 800 billion yuan, resulting in a net injection of 100 billion yuan after accounting for maturing repos [3] - The central bank's Shanghai headquarters is actively promoting financial reforms in the free trade zone, aiming to enhance cross-border financial services and the convenience of cross-border RMB business [3] Group 3: International News - The U.S. House of Representatives approved a funding bill to end a partial government shutdown, with a vote of 217 to 214, sending the bill to the President for signature [4] - Despite the approval, a funding shortfall risk remains, particularly for the Department of Homeland Security, which has funding only until February 13 [4] Group 4: Commodity Market - International crude oil prices rose, with WTI crude up 1.72% to $63.21 per barrel and Brent crude up 1.56% to $67.33 per barrel [5] - Gold futures increased by 6.94% to $4975.30 per ounce, while natural gas prices rose by 3.49% to $3.377 per million British thermal units [5] Group 5: Bond Market Dynamics - The bond market showed mixed performance, with short-term bonds weaker and medium to long-term bonds slightly stronger; the yield on the 10-year government bond fell by 0.40 basis points to 1.8110% [9] - The central bank conducted a 7-day reverse repo operation with a total of 1055 billion yuan at a rate of 1.40%, resulting in a net withdrawal of 2965 billion yuan due to maturing repos [6][7] Group 6: Credit Bonds - No credit bonds showed price deviations exceeding 10% on February 3, indicating stable trading conditions in the secondary market [11] - Companies like Zhongjun Group and Yida China are facing financial difficulties, with Zhongjun unable to repay a bond and Yida receiving a lawsuit for debt recovery [11][12] Group 7: Convertible Bonds - The convertible bond market saw a collective rebound, with major indices rising between 2.51% and 2.79%, and trading volume increasing significantly [13] - Notable individual bonds like Baichuan Convertible Bond surged over 17%, while some bonds experienced declines, such as Huazheng Convertible Bond, which fell over 4% [14] Group 8: Overseas Bond Market - U.S. Treasury yields showed mixed movements, with the 10-year yield down 1 basis point to 4.28%, while the 2-year yield remained unchanged at 3.57% [16] - European government bond yields generally increased, with Germany's 10-year yield rising by 2 basis points to 2.89% [18]

FF305 表格類別： 股票 狀態： 新提交 公司名稱： 山東威高集團醫用高分子製品股份有限公司 呈交日期： 2026年2月3日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01066 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | ...